Leidos (LDOS) Enters Into An Alliance With Clarify Health
Zacks Investment Research | Jan 13, 2020 09:03PM ET
Leidos Holdings, Inc. (NYSE:LDOS) and Clarify Health Solutions Inc. recently signed a partnership for delivering advanced analytic solutions to healthcare partners. Per the agreement terms, Leidos will deliver Clarify-generated predictive insights, directly into a customer’s healthcare operations, through its careC2 platform.
Rationale Behind the Alliance
In recent times, it has been observed that companies specializing in providing advanced analytics are focusing on delivering complex and contrasting health data into actionable insights, with the intention of facilitating improved healthcare operations. This, in turn, has been boosting the growth prospects of the global healthcare analytics market.
Notably, per Markets and Markets Research, the global healthcare analytics market is expected to see a CAGR of 28.3% from $14 billion in 2019 to $50.5 billion by 2024. In line with this, Leidos and Clarify Health's latest alliance is primarily aimed at capturing the larger share of this growing market in the days to come.
How Will This Alliance Benefit Leidos?
Clarify Health currently has one of the largest patient-level datasets in healthcare, which it uses to generate valuable predictive healthcare insights. These insights are widely used by clients across health systems, health plans and life sciences companies. Meanwhile, Leidos’ careC2 platform provides customers with tools to design, build and commercialize their own applications and get a real-time view of their healthcare operations.
Notably, owing to the alliance, Leidos will be in a position to combine the existing abilities of its careC2 data services with Clarify Health’s analytics capabilities. The advanced predictive data insights gained through the combined expertise of both companies will ultimately improve the value of Leidos’ customers and increase performance transparency in healthcare.
Price Movement
In a year’s time, shares of Leidos have surged 85.9% compared with the Original post
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.